Ruperto, N; Brunner, HI; Zuber, Z; Tzaribachev, N; Kingsbury, DJ; Foeldvari, I; Horneff, G; Smolewska, E; Vehe, RK; Hazra, A; et al.
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.
Pediatric Rheumatology Online Journal.
2017;
15.
Kimura, Y; Grevich, S; Beukelman, T; Morgan, E; Nigrovic, PA; Mieszkalski, K; Graham, TB; Ibarra, M; Ilowite, N; Klein-Gitelman, M; et al.
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
Pediatric Rheumatology Online Journal.
2017;
15.
Brachat, AH; Grom, AA; Wulffraat, N; Brunner, HI; Quartier, P; Brik, R; McCann, L; Ozdogan, H; Rutkowska-Sak, L; Schneider, R; et al.
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy.
Arthritis Research and Therapy.
2017;
19.
Langefeld, CD; Ainsworth, HC; Graham, DS C; Kelly, JA; Comeau, ME; Marion, MC; Howard, TD; Ramos, PS; Croker, JA; Morris, DL; et al.
Transancestral mapping and genetic load in systemic lupus erythematosus.
Nature Communications.
2017;
8.
Morgan, EM; Riebschleger, MP; Horonjeff, J; Consolaro, A; Munro, JE; Thornhill, S; Beukelman, T; Brunner, HI; Creek, EL; Harris, JG; et al.
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.
The Journal of rheumatology.
2017;
44:1884-1888.
Turnier, JL; Fall, N; Thornton, S; Witte, D; Bennett, MR; Appenzeller, S; Klein-Gitelman, MS; Grom, AA; Brunner, HI.
Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Arthritis Research and Therapy.
2017;
19.
Feldon, M; Farhadi, PN; Brunner, HI; Itert, L; Goldberg, B; Faiq, A; Wilkerson, J; Rose, KM; Rider, LG; Miller, FW; et al.
Predictors of Reduced Health-Related Quality of Life in Adult Patients With Idiopathic Inflammatory Myopathies.
Arthritis Care and Research.
2017;
69:1743-1750.
Bennett, MR; Ma, Q; Ying, J; Devarajan, P; Brunner, H.
Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).
Pediatric Rheumatology Online Journal.
2017;
15.
AlE'ed, A; Vega-Fernandez, P; Muscal, E; Hinze, CH; Tucker, LB; Appenzeller, S; Bader-Meunier, B; Roth, J; Torrente-Segarra, V; Klein-Gitelman, MS; et al.
Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood.
Arthritis Care and Research.
2017;
69:1449-1459.
Bernatsky, S; Clarke, AE; Niaki, OZ; Labrecque, J; Schanberg, LE; Silverman, ED; Hayward, K; Imundo, L; Brunner, HI; Haines, KA; et al.
Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
The Journal of rheumatology.
2017;
44:1484-1486.
Ruperto, N; Brunner, HI; Lovell, DJ; Martini, A.
Extrapolation or controlled trials in paediatrics: The current dilemma.
Sexually Transmitted Infections.
2017;
102:949-951.
Oni, L; Beresford, MW; Witte, D; Chatzitolios, A; Sebire, N; Abulaban, K; Shukla, R; Ying, J; Brunner, HI.
Inter-observer variability of the histological classification of lupus glomerulonephritis in children.
Lupus.
2017;
26:1205-1211.
Ruperto, N; Brunner, HI; Lovell, DJ; Martini, A; Trials, PR I; PRCSG, .
Extrapolation or controlled trials in paediatrics: the current dilemma.
Sexually Transmitted Infections.
2017;
102:949-951.
Gulati, G; Bennett, MR; Abulaban, K; Song, H; Zhang, X; Ma, Q; Brodsky, SV; Nadasdy, T; Haffner, C; Wiley, K; et al.
Prospective validation of a novel renal activity index of lupus nephritis.
Lupus.
2017;
26:927-936.
Brunner, HI; Bennett, MR; Gulati, G; Abulaban, K; Klein-Gitelman, MS; Ardoin, SP; Tucker, LB; Rouster-Stevens, KA; Witte, D; Ying, J; et al.
Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
The Journal of rheumatology.
2017;
44:1239-1248.
Phillippi, K; Hoeltzel, M; Byun Robinson, A; Kim, S; Abramson, LS; Anderson, ES; Becker, ML; Benham, H; Beukelman, T; Blier, PR; et al.
Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.
The Journal of Pediatrics.
2017;
184:38-44.e1.
Wenderfer, SE; Ruth, NM; Brunner, HI.
Advances in the care of children with lupus nephritis.
Pediatric Research.
2017;
81:406-414.
Gulati, G; Jones, JT; Lee, G; Altaye, M; Beebe, DW; Meyers-Eaton, J; Wiley, K; Brunner, HI; DiFrancesco, MW.
Altered Blood-Brain Barrier Permeability in Patients With Systemic Lupus Erythematosus: A Novel Imaging Approach.
Arthritis Care and Research.
2017;
69:299-305.
Yu, T; Enioutina, EY; Brunner, HI; Vinks, AA; Sherwin, CM.
Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus.
Clinical Pharmacokinetics.
2017;
56:107-125.
Brachat, AH; Grom, AA; Wulffraat, N; Brunner, HI; Quartier, P; Brik, R; McCann, L; Ozdogan, H; Rutkowska-Sak, L; Schneider, R; et al.
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy.
Arthritis Research and Therapy.
2017;
19.
Jones, JT; Carle, AC; Wootton, J; Liberio, B; Lee, J; Schanberg, LE; Ying, J; DeWitt, EM; Brunner, HI.
Validation of Patient-Reported Outcomes Measurement Information System Short Forms for Use in Childhood-Onset Systemic Lupus Erythematosus.
Arthritis Care and Research.
2017;
69:133-142.
Brunner, HI; Abulaban, KM.
Pediatric and neonatal lupus.
Pediatric Rheumatology: A Clinical Viewpoint.
:
Springer Singapore;
Springer Singapore;
2017.